CURE Pharmaceutical Holding Corp

Company Snapshot
1620 Beacon Place
Oxnard, CA 93033
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 19
https://www.curepharmaceutical.com
Please select from the dropdown
  1. Executive Compensation
  2. > CURE Pharmaceutical Holding Corp
Company Financials

2021
2022
2023
Gross Profit
$4,382,000
$3,339,000
$3,109,000
Operating Income
-$16,867,000
-$8,386,000
-$6,011,000
Net Income
-$13,193,000
-$25,509,000
-$3,444,000
2021
Gross Profit
$4,382,000
Operating Income
-$16,867,000
Net Income
-$13,193,000
2022
Gross Profit
$3,339,000
Operating Income
-$8,386,000
Net Income
-$25,509,000
2023
Gross Profit
$3,109,000
Operating Income
-$6,011,000
Net Income
-$3,444,000
The above data on CURE Pharmaceutical Holding Corp came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Robert Davidson
Chairman of the Board and Chief Executive Officer
$175,833
$274,683
$15,082
$465,598
Robert Davidson
$465,598
Chairman of the Board and Chief Executive Officer
Jessica Rousset
Chief Operating Officer
$180,000
$237,868
$19,284
$437,152
Jessica Rousset
$437,152
Chief Operating Officer
Mark Udell
Chief Accounting Officer, Chief Financial Officer, Treasurer and Secretary
$115,000
$89,258
$0
$204,258
Mark Udell
$204,258
Chief Accounting Officer, Chief Financial Officer, Treasurer and Secretary
William Yuan
Director
$0
$89,258
$0
$89,258
William Yuan
$89,258
Director
Edward Maliski
Chief Scientific Officer and President
$32,924
$29,753
$0
$62,677
Edward Maliski
$62,677
Chief Scientific Officer and President
CURE Pharmaceutical Holding Corp listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2018. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us